X4 Pharmaceuticals (XFOR) Tax Provisions (2020 - 2025)
X4 Pharmaceuticals (XFOR) reported Tax Provisions of -$30000.0 for Q3 2025, down 300.0% on a YoY basis from $15000.0 in Q3 2024, and down 181.08% quarter-over-quarter from $37000.0 in Q2 2025.
X4 Pharmaceuticals (XFOR) Tax Provisions (2020 - 2025) Analysis & Trends
X4 Pharmaceuticals has reported Tax Provisions for 6 years, with the latest figure at -$30000.0 in Q3 2025.
- For the quarter ending Q3 2025, Tax Provisions fell 300.0% year-over-year to -$30000.0; the trailing twelve-month figure through Dec 2025 stood at $41000.0 (down 86.77% YoY), and the FY2025 full-year result was $41000.0, down 86.77% from the prior year.
- Tax Provisions for Q3 2025 stood at -$30000.0, down from $37000.0 in the prior quarter.
- The five-year high for Tax Provisions was $258000.0 in Q4 2024, with the low at -$30000.0 in Q3 2025.
- Historically, Tax Provisions has averaged $24947.4 across 5 years, with a median of $15000.0 in 2023.
- Annual changes were most pronounced in 2022 — Tax Provisions plunged 750.0% — and 2024, when it surged 681.82%.
- X4 Pharmaceuticals' Tax Provisions stood at $3000.0 in 2021, then jumped by 366.67% to $14000.0 in 2022, then surged by 135.71% to $33000.0 in 2023, then surged by 681.82% to $258000.0 in 2024, then sank by 111.63% to -$30000.0 in 2025.
- The last three Tax Provisions figures came in at -$30000.0 (Q3 2025), $37000.0 (Q2 2025), and $34000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 216,000.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | X4 Pharmaceuticals | 156.06 Mn | 156.06 Mn | 2.20 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30,000.00 |
| Jun 30, 2025 | 37,000.00 |
| Mar 31, 2025 | 34,000.00 |
| Dec 31, 2024 | 258,000.00 |
| Sep 30, 2024 | 15,000.00 |
| Jun 30, 2024 | 18,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 33,000.00 |
| Sep 30, 2023 | 26,000.00 |
| Jun 30, 2023 | 15,000.00 |
| Mar 31, 2023 | 4,000.00 |
| Dec 31, 2022 | 14,000.00 |
| Sep 30, 2022 | -13,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 23,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 2,000.00 |
| Jun 30, 2021 | 6,000.00 |
| Mar 31, 2021 | 6,000.00 |
| Mar 31, 2020 | 148,000.00 |